Integra Lifesciences Holdings Corp  

(Public, NASDAQ:IART)   Watch this stock  
Find more results for IART
70.82
+0.70 (1.00%)
Apr 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 69.34 - 71.08
52 week 54.75 - 72.05
Open 70.21
Vol / Avg. 417,073.00/278,123.00
Mkt cap 2.66B
P/E 309.11
Div/yield     -
EPS 0.23
Shares 37.22M
Beta 0.68
Inst. own 85%
May 24, 2016
Integra LifeSciences Holdings Corp Annual Shareholders Meeting - 9:00AM EDT - Add to calendar
May 20, 2016
Integra LifeSciences Holdings Corp Annual Shareholders Meeting (Estimated) - 9:00AM EDT - Add to calendar
Apr 27, 2016
Q1 2016 Integra LifeSciences Holdings Corp Earnings Release
Apr 27, 2016
Q1 2016 Integra LifeSciences Holdings Corp Earnings Call
Mar 15, 2016
Integra LifeSciences Holdings Corp at Barclays Global Healthcare Conference
Mar 7, 2016
Integra LifeSciences Holdings Corp at Raymond James Institutional Investors Conference
Mar 1, 2016
Integra LifeSciences Holdings Corp at Canaccord Genuity Musculoskeletal Conference
Feb 25, 2016
Q4 2015 Integra LifeSciences Holdings Corp Earnings Call
Feb 25, 2016
Q4 2015 Integra LifeSciences Holdings Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 4.92% 0.78%
Operating margin 9.34% 9.18%
EBITD margin - 21.08%
Return on average assets - 0.41%
Return on average equity - 0.94%
Employees 3,500 -
CDP Score - -

Address

311 Enterprise Dr
PLAINSBORO, NJ 08536-3344
United States - Map
+1-609-2750500 (Phone)
+1-609-2755363 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Integra LifeSciences Holdings Corporation is a medical technology company. The Company offers solutions, such as orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. The Company's operating segments are: Specialty Surgical Solutions, and Orthopedics and Tissue Technologies. The Company's Specialty Surgical Solutions segment includes the Neurosurgery business and the Instruments business. The Company's Orthopedics and Tissue Technologies segment includes offerings, such as skin and wound repair, bone and joint fixation, implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The Company sources its handheld surgical instruments and specialty metal and pyrocarbon implants through third-party vendors. The Company manufactures its products in plants, which are located in the United States, Puerto Rico, France, Germany, Ireland and Mexico.

Officers and directors

Stuart M. Essig Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Peter J. Arduini President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Glenn G Coleman Chief Financial Officer, Corporate Vice President
Age: 47
Bio & Compensation  - Reuters
Padma Thiruvengadam Chief Human Resources Officer, Corporate Vice President - Strategic Initiatives and Operational Excellence
Age: 50
Bio & Compensation  - Reuters
Kenneth Burhop Ph.D. Chief Scientific Officer, Corporate Vice President
Age: 61
Bio & Compensation  - Reuters
John Mooradian Corporate Vice President - Global Operations and Supply Chain
Age: 59
Bio & Compensation  - Reuters
Richard D. Gorelick Corporate Vice President, General Counsel, Administration, Secretary
Age: 54
Bio & Compensation  - Reuters
Mark A. Augusti Corporate Vice President, President - Orthopedics and Tissue Technologies
Age: 49
Bio & Compensation  - Reuters
Robert T. Davis Jr. Corporate Vice President, President - Specialty Surgical Solutions
Age: 56
Bio & Compensation  - Reuters
Deborah Leonetti Corporate Vice President - Global Services and Repair
Age: 59
Bio & Compensation  - Reuters